Kenneth Dakin, PA-C
NPI 1740420306 · Physician Assistant · Dallas, TX
Enrolled with Medicare as Practitioner - Physician Assistant · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Kenneth Dakin, PA-C is a Physician Assistant provider in Dallas, TX (NPI 1740420306).
Provider details
- NPI number
- 1740420306
- Entity type
- Individual
- Primary specialty
- Physician AssistantPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- PA-C
- Sex
- Male
- Sole proprietor
- No
- License
- PA06088 (TX)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
17 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
81 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 22 | $107 |
| Detection Test By Immunoassay Technique for Severe Acute Respiratory Syndrome Coronavirus and Influenza87428 | 18 | $69 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 16 | $12 |
| Detection Test By Immunoassay Technique for Respiratory Syncytial Virus (rsv)87420 | 13 | $14 |
| Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep)87880 | 12 | $16 |
Typical Medicare-allowed amounts for these services range $12–$107 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisone | 18 | 18 |
| Amoxicillin/Potassium Clavbrand: Amoxicillin-Clavulanate Potass | 12 | 12 |
| Buprenorphine Hcl/Naloxone Hclbrand: Buprenorphine-Naloxone | 11 | — |
| Ondansetronbrand: Ondansetron Odt | 11 | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$40 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-02-23
- Last updated
- 2012-01-25
Frequently asked questions
- What is Kenneth Dakin's NPI number?
- Kenneth Dakin's National Provider Identifier (NPI) is 1740420306, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Kenneth Dakin's specialty?
- Kenneth Dakin is listed in the NPPES registry with a primary specialty of Physician Assistant (Physician Assistants & Advanced Practice Nursing Providers).
- Where is Kenneth Dakin located?
- Kenneth Dakin's practice location on file with NPPES is 12221 Merit Dr Ste 1610, Dallas, TX 75251-2204.
- What is Kenneth Dakin's phone number?
- The practice phone number listed in the NPPES registry for Kenneth Dakin is (214) 217-1911.
- Does Kenneth Dakin accept Medicare?
- Kenneth Dakin is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Kenneth Dakin's NPI active?
- Yes — Kenneth Dakin's NPI (1740420306) is active in the NPPES registry as of the last update on 2012-01-25.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.